La Jolla Labs
La Jolla Labs Inc. is a therapeutics company specializing in the design and discovery of RNA-targeting therapeutics, leveraging modern RNA biology, machine learning, and automation to develop precision medicines. Their platform includes machine learning-driven bioinformatics tools, high-throughput screening technology using robotics and automation, and an RNA splicing software called LJSplice that aids in designing targeted splicing strategies. The company serves clients in the pharmaceutical and biotechnology sectors, aiming to accelerate drug discovery from target identification to lead compound development, with a focus on neuro indications and expanding therapeutic target space.
La Jolla Labs
La Jolla Labs Inc. is a therapeutics company specializing in the design and discovery of RNA-targeting therapeutics, leveraging modern RNA biology, machine learning, and automation to develop precision medicines. Their platform includes machine learning-driven bioinformatics tools, high-throughput screening technology using robotics and automation, and an RNA splicing software called LJSplice that aids in designing targeted splicing strategies. The company serves clients in the pharmaceutical and biotechnology sectors, aiming to accelerate drug discovery from target identification to lead compound development, with a focus on neuro indications and expanding therapeutic target space.
TL;DR
Founded: 2020
Focus: RNA-targeting therapeutics and discovery platform
Core tech: ML-driven oligonucleotide design, LJSplice software, automated high-throughput ASO screening
Headquarters / lab: El Cajon / Greater San Diego area
Recent funding: Seed round closed Jan 2022; investor: NFX Bio
Company Overview
Problem Domain
Discovery and development of RNA-targeting therapeutics, including splicing-targeted approaches and antisense oligonucleotides (ASOs).
Founded
2020
Industry
Biotechnology
Tech Stack
Funding Track Record
Investor Signal
“NFX Bio (investor participation in Seed round)”